ROLE OF PLATELET-RICH PLASMA AS A TREATMENT FOR PLANTAR FASCIITIS

Main Article Content

Dr Vikas Mittal
Dr Ajay Kumar Yadav
Dr gaurav singh

Keywords

meta-analysis, plantar fasciitis, platelet-rich plasma, randomized controlled trials

Abstract

Background: Recently, platelet-rich plasma (PRP) has been used as an alternative therapy for plantar fasciitis (PF) to reduce heel pain and improve functional restoration. We evaluated the current evidence concerning the efficacy and safety of PRP as a treatment for PF compared with the efficacy and safety of steroid treatments.


Methods: Databases (PubMed, EMBASE, and The Cochrane Library) were searched from their establishment to January 30, 2020, for randomized controlled trials (RCTs) comparing PRP with steroid injections as treatments for PF. The Cochrane risk of bias (ROB) tool was used to assess the methodological quality. Outcome measurements were the visual analogue scale (VAS), Foot and Ankle Disability Index (FADI), American Orthopedic Foot and Ankle Society (AOFAS) scale, and the Roles and Maudsley score (RMS). The statistical analysis was performed with RevMan 5.3.5 software.


Results: Nine RCTs (n = 430) were included in this meta-analysis. Significant differences in the VAS were not observed between the 2 groups after 4 [weighted mean difference (WMD) = 0.56, 95% confidence interval (95% CI): −1.10 to 2.23, P = .51, I2 = 89%] or 12 weeks of treatment (WMD = −0.49, 95% CI: −1.42 to 0.44, P = .30, I2 = 89%). However, PRP exhibited better efficacy than the steroid treatment after 24 weeks (WMD = −0.95, 95% CI: −1.80 to −0.11, P = .03, I2 = 85%). Moreover, no significant differences in the FADI, AOFAS, and RMS were observed between the 2 therapies (P > .05).


 


Conclusion: Limited evidence supports the conclusion that PRP is superior to steroid treatments for long-term pain relief; however, significant differences were not observed between short and intermediate effects. Because of the small sample size and the limited number of high-quality RCTs, additional high-quality RCTs with larger sample sizes are required to validate this result.

Abstract 36 | pdf Downloads 6

References

[1].Schwartz EN, Su J. Plantar fasciitis: a concise review. Perm J 2014;18:e105–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
[2].Cole C, Seto C, Gazewood J. Plantar fasciitis: evidence-based review of diagnosis and therapy. Am Fam Physician 2005;72:2237–42. [PubMed] [Google Scholar]
[3].Irving DB, Cook JL, Menz HB. Factors associated with chronic plantar heel pain: a systematic review. J Sci Med Sport 2006;9:11–22. discussion 23–4. [DOI] [PubMed] [Google Scholar]
[4].Buchbinder R. Clinical practice. Plantar fasciitis. N Engl J Med 2004;350:2159–66. [DOI] [PubMed] [Google Scholar]
[5].Taunton JE, Ryan MB, Clement DB, et al. A retrospective case-control analysis of 2002 running injuries. Br J Sports Med 2002;36:95–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
[6].Dastgir N. Extracorporeal shock wave therapy for treatment of plantar fasciitis. J Pak Med Assoc 2014;64:675–8. [PubMed] [Google Scholar]
[7].Salvi AE. Targeting the plantar fascia for corticosteroid injection. J Foot Ankle Surg 2015;54:683–5. [DOI] [PubMed] [Google Scholar]
[8].Johnson RE, Haas K, Lindow K, et al. Plantar fasciitis: what is the diagnosis and treatment? Orthop Nurs 2014;33:198–204. quiz 205–196. [DOI] [PubMed] [Google Scholar]
[9].Porter MD, Shadbolt B. Intralesional corticosteroid injection versus extracorporeal shock wave therapy for plantar fasciopathy. Clin J Sport Med 2005;15:119–24. [DOI] [PubMed] [Google Scholar]
[10].Goff JD, Crawford R. Diagnosis and treatment of plantar fasciitis. Am Fam Physician 2011;84:676–82. [PubMed] [Google Scholar]
[11].Podolsky R, Kalichman L. Taping for plantar fasciitis. J Back Musculoskelet Rehab 2015;28:1–6. [DOI] [PubMed] [Google Scholar]
[12].Ogden JA, Alvarez RG, Marlow M. Shockwave therapy for chronic proximal plantar fasciitis: a meta-analysis. Foot Ankle Int 2002;23:301–8. [DOI] [PubMed] [Google Scholar]
[13].Neufeld SK, Cerrato R. Plantar fasciitis: evaluation and treatment. J Am Acad Orthop Surg 2008;16:338–46. [DOI] [PubMed] [Google Scholar]
[14].Wei LC, Lei GH, Sheng PY, et al. Efficacy of platelet-rich plasma combined with allograft bone in the management of displaced intra-articular calcaneal fractures: a prospective cohort study. J Orthop Res 2012;30:1570–6. [DOI] [PubMed] [Google Scholar]
[15].Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013;41:356–64. [DOI] [PubMed] [Google Scholar]
[16].Dragoo JL, Wasterlain AS, Braun HJ, et al. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med 2014;42:610–8. [DOI] [PubMed] [Google Scholar]
[17].Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004;62:489–96. [DOI] [PubMed] [Google Scholar]
[18].Higgins JP, Altman DG, Gotzsche PC, et al. Cochrane Bias Methods, G. Cochrane Statistical Methods. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
[19].Acosta-Olivo C, Elizondo-Rodriguez J, Lopez-Cavazos R, et al. Plantar fasciitis. A comparison of treatment with intralesional steroids versus platelet-rich plasma (PRP). A randomized, blinded study. J Am Podiatr Med Assoc 2016;[Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
[20].Aksahin E, Dogruyol D, Yuksel HY, et al. The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis. Arch Orthop Trauma Surg 2012;132:781–5. [DOI] [PubMed] [Google Scholar]
[21].Jain K, Murphy PN, Clough TM. Platelet Rich Plasma Versus Corticosteroid Injection for Plantar Fasciitis: A Comparative Study. In: Foot (Edinburgh, Scotland), 2015, 235–237. [DOI] [PubMed] [Google Scholar]
[22].Mahindra P, Yamin M, Selhi HS, et al. Chronic plantar fasciitis: effect of platelet-rich plasma, corticosteroid, and placebo. Orthopedics 2016;39:e285–9. [DOI] [PubMed] [Google Scholar]
[23].Omar AS, Ibrahim ME, Ahmed AS, et al. Local injection of autologous platelet rich plasma and corticosteroid in treatment of lateral epicondylitis and plantar fasciitis: Randomized clinical trial. The Egyptian Rheumatologist 2012;34:43–9. [Google Scholar]
[24].Say F, Gurler D, Inkaya E, et al. Comparison of platelet-rich plasma and steroid injection in the treatment of plantar fasciitis. Acta Orthop Traumatol Turc 2014;48:667–72. [DOI] [PubMed] [Google Scholar]
[25].Shetty VD, Dhillon M, Hegde C, et al. A study to compare the efficacy of corticosteroid therapy with platelet-rich plasma therapy in recalcitrant plantar fasciitis: a preliminary report. J Foot Ankle Surg 2014;20:10–3. [DOI] [PubMed] [Google Scholar]
[26].Tiwari M, Bhargava R. Platelet rich plasma therapy: a comparative effective therapy with promising results in plantar fasciitis. J Clin Orthop Trauma 2013;4:31–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
[27].Vahdatpour B, Kianimehr L, Moradi A, et al. Beneficial effects of platelet-rich plasma on improvement of pain severity and physical disability in patients with plantar fasciitis: a randomized trial. Adv Biomed Res 2016;5:179. [DOI] [PMC free article] [PubMed] [Google Scholar]
[28].Beeson P. Plantar fasciopathy: revisiting the risk factors. Foot Ankle Surg 2014;20:160–5. [DOI] [PubMed] [Google Scholar]
[29].Kirkland P, Beeson P. Use of primary corticosteroid injection in the management of plantar fasciopathy: is it time to challenge existing practice? J Am Podiatr Med Assoc 2013;103:418–29. [DOI] [PubMed] [Google Scholar]
[30].Buccilli TA, Jr, Hall HR, Solmen JD. Sterile abscess formation following a corticosteroid injection for the treatment of plantar fasciitis. J Foot Ankle Surg 2005;44:466–8. [DOI] [PubMed] [Google Scholar]
[31].Acevedo JI, Beskin JL. Complications of plantar fascia rupture associated with corticosteroid injection. Foot Ankle Int 1998;19:91–7. [DOI] [PubMed] [Google Scholar]
[32].Lemont H, Ammirati KM, Usen N. Plantar fasciitis: a degenerative process (fasciosis) without inflammation. J Am Podiatr Med Assoc 2003;93:234–7. [DOI] [PubMed] [Google Scholar]
[33].Barrett SJ, O’Malley R. Plantar fasciitis and other causes of heel pain. Am Fam Physician 1999;59:2200–6. [PubMed] [Google Scholar]
[34].Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med 2003;33:381–94. [DOI] [PubMed] [Google Scholar]
[35].Martinelli N, Marinozzi A, Carni S, et al. Platelet-rich plasma injections for chronic plantar fasciitis. Int Orthop 2013;37:839–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
[36].Fenwick SA, Hazleman BL, Riley GP. The vasculature and its role in the damaged and healing tendon. Arthritis Res 2002;4:252–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
[37].Anitua E, Pino A, Orive G. Plasma rich in growth factors promotes dermal fibroblast proliferation, migration and biosynthetic activity. J Wound Care 2016;25:680–7. [DOI] [PubMed] [Google Scholar]
[38].Wang JH, Nirmala X. Application of tendon stem/progenitor cells and platelet-rich plasma to treat tendon injuries. Oper Tech Orthop 2016;26:68–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
[39].Chou LC, Liou TH, Kuan YC, et al. Autologous blood injection for treatment of lateral epicondylosis: a meta-analysis of randomized controlled trials. Phys Ther Sport 2016;18:68–73. [DOI] [PubMed] [Google Scholar]
[40].Li Z, Yu A, Qi B, et al. Corticosteroid versus placebo injection for plantar fasciitis: a meta-analysis of randomized controlled trials. Exp Ther Med 2015;9:2263–8. [DOI] [PMC free article] [PubMed] [Google Scholar]